As part of the collaboration, the drugmaker will use Immunai's AI model of the immune system and machine learning for ...

New machine learning techniques plumb vast "data lakes" to help researchers design faster, cheaper, more effective clinical ...

TxGNN is the first AI model specifically developed to identify drug candidates for rare diseases and conditions with no ...

Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...

Gilead Sciences has partnered with Genesis Therapeutics to discover and develop new small molecule therapies using AI.

A new artificial intelligence model developed by researchers at The University of Texas at Austin paves the way for more ...

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party ...

Phare Bio, along with the Collins Lab at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute, today ...

By improving triage, an artificial intelligence program could significantly aid emergency departments that are often ...

Aethlon's Hemopurifier® is a clinical stage immunotherapeutic device designed to combat cancer. Read the full article at Investorideas.com According to News-Medical.net, "Immunotherapy, which works ...

In the completed Phase 1/2a clinical trial (NCT03715985), assessing EVX-01 in combination with a PD-1 inhibitor, eight of twelve metastatic melanoma patients (67%) had objective clinical responses ...